Atlas Trials

Bioavailability Study of ODM-201 in Subjects With Metastatic Chemotherapy-naive Castration-resistant Prostate Cancer

Clinical trial NCT01784757 · COMPLETED

Trial details

NCT number
NCT01784757
Sponsor
Orion Corporation, Orion Pharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2013-03-01
Primary completion
2013-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.